Growth Metrics

Medicale (MCLE) Equity Ratio (2020 - 2024)

Medicale's Equity Ratio history spans 5 years, with the latest figure at 727.13 for Q4 2024.

  • For Q4 2024, Equity Ratio fell 92.6% year-over-year to 727.13; the TTM value through Dec 2024 reached 727.13, down 92.6%, while the annual FY2024 figure was 622.22, 142.96% down from the prior year.
  • Equity Ratio reached 727.13 in Q4 2024 per MCLE's latest filing, down from 622.22 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.15 in Q1 2021 to a low of 727.13 in Q4 2024.
  • Average Equity Ratio over 5 years is 221.04, with a median of 112.93 recorded in 2023.
  • Peak YoY movement for Equity Ratio: plummeted 3363.01% in 2022, then crashed 92.6% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 1.11 in 2020, then tumbled by 93.12% to 2.15 in 2021, then tumbled by 3363.01% to 74.47 in 2022, then crashed by 406.94% to 377.53 in 2023, then plummeted by 92.6% to 727.13 in 2024.
  • Per Business Quant, the three most recent readings for MCLE's Equity Ratio are 727.13 (Q4 2024), 622.22 (Q3 2024), and 516.05 (Q2 2024).